Performance of released quantitative AI tools for predicting antimicrobial peptide MIC

Source article: A Retrospective Benchmark of Quantitative Antimicrobial Peptide Activity Prediction Tools

Antimicrobial peptides (AMPs) are critical candidates for addressing the global antibiotic resistance crisis. AI-driven quantitative models capable of directly predicting peptide antimicrobial activity, specifically minimum inhibitory concentration (MIC), are gaining scientific prominence by providing precise guidance for the rational design of AMPs. To assess their real-world, out-of-the-box performance, we conducted a retrospective benchmark of 10 publicly released quantitative AMP prediction tools spanning cl…

A Retrospective Benchmark of Quantitative Antimicrobial Peptide Activity Prediction Tools
"Work Bench - Microbiology Laboratory, Spotswood Sewerage Pumping Station, Victoria, circa 1939" is licensed under CC BY 4.0. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
Trace impact readingContested
P 67The P score combines the specificity and measured human impact of the grounded problem claim with the strength of this Trace’s cited sources.

Both sides are scored from claims and sources, not community votes.

G 65The G score combines the specificity and measured human impact of the grounded gain claim with the strength of this Trace’s cited sources.

In brief

Researchers benchmarked 10 publicly released quantitative prediction tools for antimicrobial peptides, covering both classical machine learning and deep learning. They tested the tools on an external dataset and on reconstructed native datasets, looking at absolute MIC regression, reproducibility, ranking ability and virtual-screening enrichment.

The results matter because antibiotic resistance drives interest in designing peptides computationally, and overreliance on weak predictors could misdirect lab effort. The study supports using the tools as early filters rather than as precise stand-ins for lab MIC measurements. The abstract does not say which tools performed best or how much lab work they could save.

Main points

  1. Ten publicly released quantitative AMP prediction tools were tested out of the box, spanning classical machine learning and deep learning.
  2. Most tools showed poor absolute MIC regression and limited transfer to the external benchmark.
  3. Some tools retained useful relative ranking and enrichment performance in virtual screening.
  4. Implementation-level reproducibility differed markedly among the released tools.
  5. Prediction errors were systematically linked to peptide residue composition, and predicted activity ranges were generally compressed.

The gain

Selected tools kept useful relative-ranking and virtual-screening enrichment ability, so they can work as early-stage filters when screening peptide candidates.

The problem

Most publicly released tools gave poor absolute MIC predictions and transferred badly to an external dataset, so they cannot replace experimental measurement.

The rundown

The evaluation used a retrospective design with an external dataset plus reconstructed native datasets. It assessed several dimensions: absolute MIC regression, retrospective reproducibility, directional prediction patterns, ranking capability and virtual-screening enrichment.

Error-stratified analyses found systematic associations between prediction errors and peptide residue composition. The predicted activity range was also generally compressed, so the models tended to squeeze the spread of true potency values.

The authors conclude that these accessible tools have practical performance boundaries. They recommend treating them as early-stage screening filters, not as precise substitutes for experimental MIC measurements, in the effort against antibiotic resistance.

What this doesn’t fix

The tools were assessed retrospectively, and most showed limited transferability to the external benchmark, so their predictions cannot stand in for experimental MIC measurements.

Sources

  1. Peer-reviewedSmall Methods2026-10-15

The debate